AAAAAA

   
Results: 1-9 |
Results: 9
CONFORMATIONAL-ANALYSIS OF HIV-1 PROTEASE INHIBITORS .2. THIOPROLINE P'(1) RESIDUE IN THE POTENT INHIBITOR KNI-272
Authors: MURCKO MA RAO BG GOMPERTS R
Citation: Ma. Murcko et al., CONFORMATIONAL-ANALYSIS OF HIV-1 PROTEASE INHIBITORS .2. THIOPROLINE P'(1) RESIDUE IN THE POTENT INHIBITOR KNI-272, Journal of computational chemistry, 18(9), 1997, pp. 1151-1166
CALCULATION OF SOLVATION AND BINDING FREE-ENERGY DIFFERENCES BETWEEN VX-478 AND ITS ANALOGS BY FREE-ENERGY PERTURBATION AND AMSOL METHODS
Authors: RAO BG KIM EE MURCKO MA
Citation: Bg. Rao et al., CALCULATION OF SOLVATION AND BINDING FREE-ENERGY DIFFERENCES BETWEEN VX-478 AND ITS ANALOGS BY FREE-ENERGY PERTURBATION AND AMSOL METHODS, Journal of computer-aided molecular design, 10(1), 1996, pp. 23-30
STRUCTURE-BASED DRUG DESIGN OF HIV PROTEASE INHIBITORS
Authors: NAVIA MA TUNG RD CHATURVEDI PR RAO BG PARTALEDIS JA KIM EE
Citation: Ma. Navia et al., STRUCTURE-BASED DRUG DESIGN OF HIV PROTEASE INHIBITORS, The FASEB journal, 10(6), 1996, pp. 2436-2436
FREE-ENERGY PERTURBATION STUDIES ON BINDING OF A-74704 AND ITS DIESTER ANALOG TO HIV-1 PROTEASE
Authors: RAO BG MURCKO MA
Citation: Bg. Rao et Ma. Murcko, FREE-ENERGY PERTURBATION STUDIES ON BINDING OF A-74704 AND ITS DIESTER ANALOG TO HIV-1 PROTEASE, Protein engineering, 9(9), 1996, pp. 767-771
KINETIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE-RESISTANT VARIANTS
Authors: PAZHANISAMY S STUVER CM CULLINAN AB MARGOLIN N RAO BG LIVINGSTON DJ
Citation: S. Pazhanisamy et al., KINETIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE-RESISTANT VARIANTS, The Journal of biological chemistry, 271(30), 1996, pp. 17979-17985
THERAPEUTIC EFFICACY OF METHYLENE-BLUE IN ACUTE EXPERIMENTAL NITRITE POISONING IN BUFFALO CALVES
Authors: RAO BG KARUNANIDHI PS CHOUDHURI PC
Citation: Bg. Rao et al., THERAPEUTIC EFFICACY OF METHYLENE-BLUE IN ACUTE EXPERIMENTAL NITRITE POISONING IN BUFFALO CALVES, Indian Veterinary Journal, 72(2), 1995, pp. 160-162
CRYSTAL-STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME
Authors: KIM EE BAKER CT DWYER MD MURCKO MA RAO BG TUNG RD NAVIA MA
Citation: Ee. Kim et al., CRYSTAL-STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME, Journal of the American Chemical Society, 117(3), 1995, pp. 1181-1182
REVERSED STEREOCHEMICAL PREFERENCE IN BINDING OF RO-31-8959 TO HIV-1 PROTEINASE - A FREE-ENERGY PERTURBATION ANALYSIS
Authors: RAO BG MURCKO MA
Citation: Bg. Rao et Ma. Murcko, REVERSED STEREOCHEMICAL PREFERENCE IN BINDING OF RO-31-8959 TO HIV-1 PROTEINASE - A FREE-ENERGY PERTURBATION ANALYSIS, Journal of computational chemistry, 15(11), 1994, pp. 1241-1253
CONFORMATIONAL-ANALYSIS OF HIV PROTEASE INHIBITORS .1. ROTATION OF THE AMIDE GROUP ADJACENT TO THE P-1(') DECAHYDROISOQUINOLINE RING-SYSTEMIN RO-31-8959 AND RELATED SYSTEMS
Authors: MURCKO MA RAO BG
Citation: Ma. Murcko et Bg. Rao, CONFORMATIONAL-ANALYSIS OF HIV PROTEASE INHIBITORS .1. ROTATION OF THE AMIDE GROUP ADJACENT TO THE P-1(') DECAHYDROISOQUINOLINE RING-SYSTEMIN RO-31-8959 AND RELATED SYSTEMS, Journal of computational chemistry, 14(12), 1993, pp. 1446-1453
Risultati: 1-9 |